| Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis T Schön, P Juréen, CG Giske, E Chryssanthou, E Sturegård, J Werngren, ... Journal of antimicrobial chemotherapy 64 (4), 786-793, 2009 | 142 | 2009 |
| What is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi-and extensively drug-resistant tuberculosis J Heyckendorf, S Andres, CU Köser, ID Olaru, T Schön, E Sturegård, ... Antimicrobial agents and chemotherapy 62 (2), 10.1128/aac. 01550-17, 2018 | 124 | 2018 |
| Reducing blood culture contamination by a simple informational intervention A Roth, AE Wiklund, AS Palsson, EZ Melander, M Wullt, J Cronqvist, ... Journal of clinical microbiology 48 (12), 4552-4558, 2010 | 121 | 2010 |
| Infection of BALB/c A mice by spiral and coccoid forms of Helicobacter pylori X Wang, E Sturegård, R Rupar, HO Nilsson, PA Aleljung, B Carlén, ... Journal of medical microbiology 46 (8), 657-663, 1997 | 112 | 1997 |
| Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid … TT Balcha, E Sturegård, N Winqvist, S Skogmar, A Reepalu, ZH Jemal, ... PloS one 9 (1), e85478, 2014 | 103 | 2014 |
| Human papillomavirus typing in reporting of condyloma E Sturegård, H Johansson, J Ekström, BG Hansson, A Johnsson, ... Sexually transmitted diseases 40 (2), 123-129, 2013 | 88 | 2013 |
| Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene … J Werngren, E Sturegård, P Juréen, K Ängeby, S Hoffner, T Schön Antimicrobial Agents and Chemotherapy 56 (3), 1253-1257, 2012 | 84 | 2012 |
| Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available … KA Ängeby, P Jureen, CG Giske, E Chryssanthou, E Sturegård, ... Journal of antimicrobial chemotherapy 65 (5), 946-952, 2010 | 70 | 2010 |
| Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis T Schön, P Juréen, E Chryssanthou, CG Giske, E Sturegård, G Kahlmeter, ... The International Journal of Tuberculosis and Lung Disease 15 (4), 502-509, 2011 | 68 | 2011 |
| High Intake of Selenium,-Carotene, and Vitamins A, C, and E Reduces Growth of Helicobacter pylori in the Guinea Pig H Sjunnesson, E Sturegård, R Willén, T Wadström Comparative Medicine 51 (5), 418-423, 2001 | 67 | 2001 |
| Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis Infections P Juréen, K Angeby, E Sturegard, E Chryssanthou, CG Giske, J Werngren, ... Journal of clinical microbiology 48 (5), 1853-1858, 2010 | 62 | 2010 |
| The relationship between O-chain expression and colonisation ability of Helicobacter pylori in a mouse model AP Moran, E Sturegård, H Sjunnesson, T Wadström, SO Hynes FEMS Immunology & Medical Microbiology 29 (4), 263-270, 2000 | 58 | 2000 |
| A borderline range for Quantiferon Gold In-Tube results J Jonsson, A Westman, J Bruchfeld, E Sturegård, H Gaines, T Schön PloS one 12 (11), e0187313, 2017 | 56 | 2017 |
| Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience S Hoffner, K Ängeby, E Sturegård, B Jönsson, A Johansson, M Sellin, ... The International journal of tuberculosis and lung disease 17 (11), 1486-1490, 2013 | 55 | 2013 |
| Detection of lipoarabinomannan in urine for identification of active tuberculosis among HIV‐positive adults in E thiopian health centres TT Balcha, N Winqvist, E Sturegård, S Skogmar, A Reepalu, ZH Jemal, ... Tropical Medicine & International Health 19 (6), 734-742, 2014 | 50 | 2014 |
| Severe Gastritis in Guinea-Pigs Infected with Helicobacter Pylori E Sturegård, H Sjunnesson, B Ho, R Willen, P Aleljung, HC Ng, ... Journal of medical microbiology 47 (12), 1123-1129, 1998 | 49 | 1998 |
| A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis E Tenland, N Krishnan, A Rönnholm, S Kalsum, M Puthia, M Mörgelin, ... Tuberculosis 113, 231-238, 2018 | 44 | 2018 |
| Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis-and HIV-endemic setting J König Walles, F Tesfaye, M Jansson, T Tolera Balcha, N Winqvist, ... PLoS One 13 (4), e0193589, 2018 | 43 | 2018 |
| A clinical scoring algorithm for determination of the risk of tuberculosis in HIV-infected adults: a cohort study performed at Ethiopian health centers TT Balcha, S Skogmar, E Sturegård, T Schön, N Winqvist, A Reepalu, ... Open forum infectious diseases 1 (3), ofu095, 2014 | 36 | 2014 |
| Plasma levels of neopterin and C-reactive protein (CRP) in tuberculosis (TB) with and without HIV coinfection in relation to CD4 cell count S Skogmar, T Schön, TT Balcha, E Sturegård, M Jansson, P Björkman PLoS One 10 (12), e0144292, 2015 | 34 | 2015 |
